wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33846405-A8FB3A30-813D-43DC-A89B-08D5E2359F4F
Q33846405-A8FB3A30-813D-43DC-A89B-08D5E2359F4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33846405-A8FB3A30-813D-43DC-A89B-08D5E2359F4F
A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
P2860
Q33846405-A8FB3A30-813D-43DC-A89B-08D5E2359F4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33846405-A8FB3A30-813D-43DC-A89B-08D5E2359F4F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc28292e0391aa7f231a53de515de4b7f566d712
P2860
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer.